FindTrial
Sign In

Efficacy and safety assessment of the programmed, modular, minimally invasive and individualized surgical strategy for severe acute pancreatitis

Establishment of individualized surgical treatment system for severe acute pancreatitis and study on multimodal imaging intelligent evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075318
Enrollment
Unknown
Registered
2023-09-01
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe acute pancreatitis

Interventions

Study group:PMMI surgical strategy
Control group:Step-up strategy with integrated Chinese and Western medicine

Sponsors

Tianjin Nankai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients were admitted to the hospital within 48 h of SAPonset. 2. According to the 2012 Atlanta classification of acute pancreatitis, patients had moderately severe acute pancreatitis and/or severe acute pancreatitis with local complications. 3. Age =18.

Exclusion criteria

Exclusion criteria: 1. Patients with past history of chronic pancreatitis. 2. Patients with previous abdominal surgery. 3. Patients who gave up treatment or were transferred midway.

Design outcomes

Primary

MeasureTime frame
morality;—

Secondary

MeasureTime frame
Comprehensive Complication Index;—

Countries

China

Contacts

Public ContactYunfeng Cui

Department of Surgery, Tianjin Nankai Hospital, Nankai Clinical School of Medicine

nkyycyf@163.com+86 150 2263 3356

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026